DIA 2017 Annual Meeting has ended

Create Your Own Event

DIA 2017 Annual Meeting

8:30am CDT

#101: Drug Repurposing: Where Will it Take Us? S105

11:00am CDT

#110: Globalization of Medical Affairs Departments S504abc #113: We Can't Forget the Children in This Process N426c #114: PDUFA at 25: A Historical View of the Prescription Drug User Fee Agreement and a Look to the Future - PDUFA VI N228 #118: Counting on Safety S401d #120: FDA Rare Disease Town Hall N227b #123: Calling All Angels to the Valley of Death S405b #126: Breaking Down the Wall for FDA to Leverage Real World Data N226 #127: The Evolving International Landscape of FDA Inspections: Data Integrity Violations in Bioequivalence Studies in India S405a #128: Office of Pharmaceutical Quality Update: Innovative Approaches in Regulatory Assessment N230b

8:00am CDT

#202: People Will Talk: Gathering Insights from Digital Listening S100c

10:30am CDT

#217: Update from CBER: Advancing the Development of Complex Biologic Products S404a #220: Cardiac Safety S401bc #208: Big Data: Regulatory Information N226 #210: The New Business Reality for the Medical Science Liaison Community S401d #212: Walking the Walk in Patient Focused Medicines Development: From Theory to Practice What Have We Learned? N426a #213: Regulatory Frameworks: How Can Regulators Facilitate Disruptive Innovation? S403ab #216: International Collaboration in Times of Public Health Crisis N229 #225: So You Say You're an Extrovert: Being an Effective Leader when All You Really Want Is a Stage S501abc #229: Outcomes Standardization: An Imperative to Value Assessments N426c

2:00pm CDT

#240: Mobile Health: Participatory Research N426c #241: FDA Session: Electronic Submissions and Data N228 #247: Best Practice for Advisory Committee Meeting Preparation S504abc #249: Not Your Grandma's Patient Advocacy Group Anymore S402ab #251: Defining the Science of Patient Input to Enhance Drug Development and Approval: Regulatory N226

4:00pm CDT

#272: Microbiome: Innovative Therapeutics, Challenges, and Opportunities S502ab #275: Partnering with Patients: Virtual and Traditional Communities - When for What S401d #277: The Reauthorization of BsUFA and its Impact on Both the Regulator and Industry N228 #278: PMDA Town Hall S404a #279: Brexit: Where Are We Now? S404bc #283: The Impact of Industry Consortia on Creating Collaborative Solutions to Drug Development Challenges: What Does the Future Hold? N426b #288: Breaking Down the Wall for Global Regulators to Leverage Real World Data N230b

8:00am CDT

#303: International Regulatory Convergence S100a

10:30am CDT

#312: CRISPR: Regulatory Challenges in the Gene Editing Revolution N228 #320: The Brave New World: The Ongoing Globalization of Pharmacovigilance N226 #323: Effective Collaborations: Navigating the Grey Space N426b #326: Optimizing Early Clinical Strategies to Support Breakthrough Therapy Designation S401a #329: Measuring and Advancing the Clinical Quality Management System S405a

2:00pm CDT

#357: Biosimilars and Generics: Access Versus Innovation S405b #339: Off-Label Communications to Health Care Providers and Consumers N229 #341: EMA Policy 0070: A Game Changer for Industry N227b #343: Expanded Access and Compassionate Use N230b #345: Global Perspective on ICH: Part 1 of 2 N228 #346: Understanding the New Common Rule and Its Impact to Industry N426b #352: Collaborative Efforts to Accelerate Rare Disease Research and Development S504abc #355: FDA, NIH, and TransCelerate Collaborate to Accelerate Drug Development Through Protocol Harmonization S404bc

4:00pm CDT

#373: FDA–Health Canada Regulatory Cooperation Council Town Hall S401d #363: EHRs/eSource and Emerging Data Streams N230b #364: Risk-Based Monitoring: Convergence of Technology, Processes, and People: Panel Discussion N226 #368: FDA Update on Prescription Drug Promotion N227b #370: Lessons Learned from the Sarepta Exondys 51 Approval S404bc #374: Global Perspective on ICH: Part 2 of 2 N228

9:00am CDT

#401: FDA Forum S105

10:45am CDT

#402: Online Patient Networking S404a #404: How Do You Build a Collaborative Community? What Advice Would You Give? N426b #412: EMA/ FDA Question Time S105